Karyopharm Therapeutics Secures $20,500,000 New Financing

  • Feed Type
  • Date
    5/2/2013
  • Company Name
    Karyopharm Therapeutics
  • Mailing Address
    2 Mercer Road Natick, MA 01760
  • Company Description
    Karyopharm Therapeutics is a biopharmaceutical company focusing on the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation.
  • Website
    http://www.karyopharm.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.